肾衰竭风险方程与美国高额医疗费用的关联
本研究为一项观察性回顾性队列研究的辅助分析,纳入1721例CKD G3和G4期患者,评估4变量和8变量2年肾衰竭风险方程(KFRE)评分与月度医疗费用的关联。结果显示,KFRE风险每绝对增加1%,8变量模型下G3和G4期患者月度费用分别升高13.5%和4.1%,4变量模型下分别升高6.7%和2.9%。作者认为KFRE可能有助于预判医疗费用并针对高危患者采取降费干预。
要点
- 8变量KFRE风险每增加1%,CKD G3期患者月度费用升高13.5%(P<0.001)。
- 8变量KFRE风险每增加1%,CKD G4期患者月度费用升高4.1%(P<0.001)。
- 4变量KFRE风险每增加1%,G3和G4期月度费用分别升高6.7%和2.9%。
核心结论
- 4变量或8变量KFRE预测的较高肾衰竭风险与CKD G3和G4期患者较高的2年医疗费用相关。
- KFRE可能是预判医疗费用并针对肾衰竭风险患者采取降费干预的有用工具。
研究设计与样本
- 本研究为一项更大规模观察性回顾性队列研究的辅助研究,该队列研究考察血清碳酸氢盐与不良肾脏结局的关联。
- 共纳入1721例患者,其中CKD G3期1475例、G4期246例。
- 月度医疗费用根据个人医疗保险索赔计算,采用广义线性回归模型分析KFRE评分与医疗费用的关联。
主要发现
- 8变量KFRE风险每绝对增加1%,CKD G3期患者月度费用升高13.5%(P<0.001),CKD G4期患者升高4.1%(P<0.001)。
- 4变量KFRE风险每增加1%,CKD G3期患者月度费用升高6.7%(P=0.016),CKD G4期患者升高2.9%(P=0.014)。
临床怎么用
- 作者认为KFRE可能是预判医疗费用并针对有肾衰竭风险患者采取降费干预的有用工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The Kidney Failure Risk Equations (KFRE) are accurate and validated to predict the risk of kidney failure in individuals with chronic kidney disease (CKD), but their potential to predict health care costs in the US health care system is unknown. We assessed the association of kidney failure risk from the 4-variable and 8-variable 2-year KFRE models with monthly health care costs in US patients with CKD stages G3 and G4. METHODS: This was an ancillary study to a larger observational, retrospective cohort study examining the association between serum bicarbonate and adverse kidney outcomes. Monthly medical costs were calculated from individual health care insurance claims. Generalized linear regression models were used to examine the association of KFRE score with health care costs. RESULTS: A total of 1721 patients qualified for the study (1475 and 246 with CKD stages G3 and G4, respectively). For 8-variable KFRE, each 1% (absolute) increase in risk was associated with 13.5% (P < 0.001) and 4.1% (P < 0.001) higher monthly costs for patients with CKD stage G3 and G4, respectively. For 4-variable KFRE, a 1% increase in risk was associated with 6.7% (P = 0.016) and 2.9% (P= 0.014) increase in monthly costs for patients with CKD stage G3 and G4, respectively. CONCLUSION: Higher risks of kidney failure as predicted by the 4-variable or 8-variable KFRE were associated with higher 2-year medical costs for patients with CKD stages G3 and G4. The KFRE may be a useful tool to anticipate medical costs and target cost-reducing interventions for patients at risk of kidney failure.
引用
- Reaven NL, Funk SE, Mathur V, et al. Association of the Kidney Failure Risk Equation With High Health Care Costs. Kidney Int Rep. 2023. PMID: 37284668. doi:10.1016/j.ekir.2023.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。